AI assistant
Advanced Enzyme Technologies Limited — Capital/Financing Update 2025
Jul 4, 2025
62369_rns_2025-07-04_14eac652-233d-4e4e-9ac7-38bee37e733c.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
July 04, 2025
BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Exchange Plaza, Plot No. C/1, G Block Mumbai-400 001 Bandra-Kurla Complex, Bandra (E) Mumbai-400 051 Scrip ID-540025 Scrip Code-ADVENZYMES
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 – Incorporation of a Wholly Owned Subsidiary.
Ref – Outcome of Board Meeting dated May 13, 2025.
Pursuant to the Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 (as amended) (“SEBI Listing Regulations”), and in furtherance to the captioned letter dated May 13, 2025 intimating that the Board of Directors of the Company has approved incorporation of a wholly-owned subsidiary, we would like to share an update that the said wholly owned subsidiary of the Company has been incorporated in India as per the Certificate of Incorporation dated July 04, 2025.
The realevant details as required under the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 are enclosed as Annexure - A.
The above information is also made available on the website of the Company at https://www.advancedenzymes.com/investors/stock-exchange-compliance/#other-compliance
Kindly take a note of the same.
Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited
SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2025.07.04 15:37:59 +05'30'
Sanjay Basantani Company Secretary and Head – Legal
Annexure A
| Name of the target entity, details in brief such as size, turnover etc |
Advanced Nutrazyme Private Limited; Other details are not applicable as the said wholly owned subsidiary is a newly incorporated company in India and is yet to commence its business. |
|---|---|
| Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” |
Not Applicable |
| Industry to which the entity being acquired belongs |
Nutrition and wellness |
| Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity); |
To carry on the business primarily of Nutrition and wellness’ range of products. |
| Brief details of any governmental or regulatory approvals required for the acquisition |
Not Applicable |
| Indicative time period for completion of the acquisition |
Not Applicable |
| Consideration - whether cash consideration or share swap or any other form and details of the same |
Cash Consideration |
| Cost of acquisition and/or the price at which the shares are acquired |
The company has been incorporated with initial subscribed share capital of₹5,00,000 i.e. 50,000 EquityShares of₹10 each |
| Percentage of shareholding / control acquired and/or number of shares |
100% shareholding |
| Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information(in brief) |
The date of incorporation is July 04, 2025 – the certificate of incorporation received by the Company on July 04, 2025. Other details are not applicable, as it’s a newlyincorporated company. |